Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF, Quadeer AA, McKay MR. · 2020
Read Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. by Ahmed SF, Quadeer AA, McKay MR. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7150947.txt.
Description
Ahmed, Quadeer, and McKay hunt for vaccine targets against the new coronavirus by reusing immune data from the 2003 SARS virus, in Viruses. The two viruses are close genetic relatives. The team screened experimentally confirmed B cell and T cell epitopes, the protein fragments the immune system recognises, from SARS-CoV's spike and nucleocapsid proteins.
A set of those fragments matched SARS-CoV-2 exactly. None had mutated among the 120 virus sequences available on 21 February 2020, so vaccines aiming at them might protect against the new virus too. Coverage analysis estimated which fragment sets would suit most people's immune types worldwide and in China. The screened list was offered to guide laboratory vaccine work.
Catalog record
| CREATOR | Ahmed SF, Quadeer AA, McKay MR. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |